“We still have a serious challenge with sickle cell disease, which contributes to 20% of under-five mortality every year.

According to the Pew Research Center, overall, 18% of Black adults report poor health, and Black Americans have higher rates ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

MultiChoice Nigeria, a leading pay TV provider and owner of DStv and GOtv, has further demonstrated its commitment to ...

Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

President Donald Trump has signed a new executive order to establish a Make America Healthy Again Commission, just hours ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Cash, cash equivalents and marketable securities as of December 31, 2024, were $1.5 billion compared to $806.4 million as of December 31, 2023.

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...